Real-time Bid/Ask 08:22:37 2024-06-06 EDT | ||
0.68 EUR / 0.75 EUR | +2.14% |
Current month | +29.63% | ||
1 month | -70.59% |
Comparison chart between the derivative product and it's underlying value
Latest news about APELLIS PHARMACEUTICALS, INC.
Date | Price | Change |
---|---|---|
24-06-06 | 0.69 | -1.43% |
24-06-05 | 0.7 | +18.64% |
24-06-04 | 0.59 | -3.28% |
24-06-03 | 0.61 | +12.96% |
24-05-31 | 0.54 | -25.00% |
Delayed Quote Börse Stuttgart
Last update June 06, 2024 at 04:21 am
More quotesStatic data
Product type | Exotic Products |
---|---|
Buy / Sell | CALL |
Underlying | APELLIS PHARMACEUTICALS, INC. |
Issuer | Morgan Stanley |
WKN | MG14X4 |
ISIN | DE000MG14X47 |
Date issued | 2024-03-27 |
Strike | 33.21 $ |
Maturity | Unlimited |
Parity | 10.68 : 1 |
Emission price | 10 € |
Emission volume | N/A |
Settlement | cash |
Currency | EUR |
Technical Indicators
Highest since issue | 13.93 € |
---|---|
Lowest since issue | 0.53 € |
Spread | 0.08 € |
Spread % | 10.67% |
Company Profile
Ratings for Apellis Pharmaceuticals, Inc.
Consensus: Apellis Pharmaceuticals, Inc.
- Stock Market
- Certificates
- Certificat